CLU and breast angiosarcoma: As per an additional role of CLU in immune response, it reportedly inhibited macrophage infiltration and proinflammatory M1 polarization in response to inflammation27, which may be a mechanistic explanation of why low circulating CLU levels were associated with poor survival in BA patients given immune dysregulation recognized as one of the pathological events driving BA development.